BIOLIFE4D Announces Intention to Submit Draft Registration Statement for Underwritten Public Offering of Common Stock BUFFALO GROVE, Ill., Dec. 31, 2021 (GLOBE NEWSWIRE) -- BIOLIFE4D Corporation today announced that it intends to submit a draft registration statement on Form S-1 with the U.S. Securities and...

BIOLIFE4D Modifies its Regulation A+ (Mini-IPO) Offering Following Significant Scientific Achievement Company surpasses $3M in accepted investments CHICAGO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for...

BIOLIFE4D Launches Second Regulation A+ (Mini-IPO) Offering Due to Popular Demand CHICAGO, Sept. 06, 2019 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has launched its...